Vedolizumab: toward a personalized therapy paradigm for people with ulcerative colitis.

Dart, Robin J; Samaan, Mark A; Powell, Nick; Irving, Peter M

Dart, Robin J; Samaan, Mark A; Powell, Nick; Irving, Peter M.

Afiliación

Dart RJ; Department of Gastroenterology, IBD Centre, St. Thomas' Hospital.
Samaan MA; Immunosurveillance Laboratory, The Francis Crick Institute, London.
Powell N; Division of Immunology, Infection, and Inflammatory Disease (DIIID), King's College London.
Irving PM; Department of Gastroenterology, IBD Centre, St. Thomas' Hospital.

Clin Exp Gastroenterol ; 10: 57-66, 2017.

Article en En | MEDLINE | ID: mdl-28424557

Palabras clave

personalized therapy; ulcerative colitis; vedolizumab

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Idioma: En Revista: Clin Exp Gastroenterol Año: 2017 Tipo del documento: Article